SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL CO.,LTD. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Stock
Equities
1349
CNE1000000W4
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.16 HKD | +1.89% |
|
+3.85% | -15.29% |
| Apr. 22 | Shanghai Fudan-Zhangjiang Buys Structured Deposits Worth 200 Million Yuan | MT |
| Apr. 01 | Fudan-Zhangjiang Bio Sees Profit, Revenue Drop in 2023 | MT |
| Sales 2022 | 1.03B 142M 1.11B | Sales 2023 | 851M 117M 919M | Capitalization | 7.32B 1.01B 7.91B |
|---|---|---|---|---|---|
| Net income 2022 | 138M 19.05M 149M | Net income 2023 | 109M 15.04M 118M | EV / Sales 2022 | 5.52 x |
| Net cash position 2022 | 1.16B 161M 1.26B | Net cash position 2023 | 1.18B 163M 1.27B | EV / Sales 2023 | 7.22 x |
| P/E ratio 2022 |
23.6
x | P/E ratio 2023 |
22.1
x | Employees | 948 |
| Yield 2022 |
2.28% | Yield 2023 |
3.02% | Free-Float | 45.47% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +1.89% | ||
| 1 week | +3.85% | ||
| Current month | +0.47% | ||
| 1 month | +0.47% | ||
| 3 months | -7.30% | ||
| 6 months | -13.60% | ||
| Current year | -15.29% |
1 week
2.08
2.18
1 month
2.032.21
Current year
2.032.59
1 year
2.033.19
3 years
2.035.73
5 years
2.039.26
10 years
2.0312.64
| Managers | Title | Age | Since |
|---|---|---|---|
Jun Li
FOU | Founder | 55 | 96-11-10 |
Da Jun Zhao
FOU | Founder | 54 | 96-11-10 |
Yan Xue
DFI | Director of Finance/CFO | 43 | 10-05-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Xiao Yang Yu
BRD | Director/Board Member | 68 | 13-05-29 |
Bo Shen
BRD | Director/Board Member | 51 | 12-06-28 |
Xiao Long Liu
BRD | Director/Board Member | 67 | 16-05-12 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +2.22% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 2.16 | +1.89% | 1 040 000 |
| 24-04-25 | 2.12 | 0.00% | 643,000 |
| 24-04-24 | 2.12 | +0.47% | 504,000 |
| 24-04-23 | 2.11 | 0.00% | 294,000 |
| 24-04-22 | 2.11 | +1.44% | 256,000 |
Delayed Quote Hong Kong S.E., April 26, 2024 at 03:57 am EDT
More quotes
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is a China-based company mainly engaged in research and development, manufacturing and marketing of biomedicine. The Company's products include aminolevulinic acid hydrochloride topical powder (trade name: ALA) and hemporfin or injection (trade name: FuMeiDa), and doxorubicin hydrochloride liposome injection (trade name: LIBOd), among others. Its products are mainly used for skin venereal disease treatment and anti-tumor treatment. The Company conducts its businesses in the domestic market.
Sector
Pharmaceuticals
Calendar
2024-04-28
- Q1 2024 Earnings Release
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -15.29% | 804M | |
| +3.89% | 69.91B | |
| +10.97% | 9.03B | |
| -17.03% | 4.75B | |
| +37.51% | 4.31B | |
| +3.92% | 3.88B | |
| +17.38% | 2.37B | |
| -24.13% | 2.26B | |
| -29.70% | 2.2B | |
| +9.09% | 1.98B |
- Stock Market
- Equities
- 1349 Stock
